Showing results (211-220 of 279) with videos related to
Sort By:
Pageof 28
BMJ (Clinical Research Ed.)|March 23, 2022
Marginalized identities, mistreatment, discrimination, and burnout among US medical students: cross sectional survey and retrospective cohort studyBethelehem G Teshome, Mayur M Desai, Cary P Gross, et al.The Laryngoscope|December 25, 2018
Disparities in adherence to head and neck cancer follow-up guidelinesHaley K Perlow, Stephen J Ramey, Vincent Cassidy, et al.Pediatric Nephrology (Berlin, Germany)|June 6, 2016
Association of blood pressure variability and neurocognition in children with chronic kidney diseaseMarc B Lande, Susan R Mendley, Matthew B Matheson, et al.Psychological Trauma : Theory, Research, Practice and Policy|September 30, 2024
Risk and protective factors associated with posttraumatic stress disorder among layperson responders to opioid overdose incidentsBrendan P Jacka, Nelson Lin, Reina Kiefer, et al.Journal of the American College of Cardiology|June 16, 2022
Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard ProtocolsTatsunori Takahashi, Bruce A Samuels, Weijia Li, et al.Academic Medicine : Journal of the Association of American Medical Colleges|May 18, 2022
Trends in U.S. MD-PhD Program Matriculant Diversity by Sex and Race/EthnicityAngela Martinez-Strengel, Elizabeth A Samuels, Jeremiah Cross, et al.JAMA Network Open|June 4, 2021
Medical Students' Demographic Characteristics and Their Perceptions of Faculty Role Modeling of Respect for DiversityJasmine Weiss, Lilanthi Balasuriya, Laura D Cramer, et al.The Cochrane Database of Systematic Reviews|March 13, 2020
Immunosuppressive agents for treating IgA nephropathyPatrizia Natale, Suetonia C Palmer, Marinella Ruospo, et al.Drugs in R&D|October 5, 2018
Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm TrialJohn M Slopis, Octavio Arevalo, Cynthia S Bell, et al.Journal of Addiction Medicine|November 26, 2024
Statewide Trends in Medications for Opioid Use Disorder Utilization in Rhode Island, United States, 2017-2023Leah C Shaw, Benjamin D Hallowell, Taylor Paiva, et al.Pageof 28